Selected article for: "endothelial cell and intravascular coagulation"

Author: Zapata, Juan Carlos; Carrion, Ricardo; Patterson, Jean L.; Crasta, Oswald; Zhang, Yan; Mani, Sachin; Jett, Marti; Poonia, Bhawna; Djavani, Mahmoud; White, David M.; Lukashevich, Igor S.; Salvato, Maria S.
Title: Transcriptome Analysis of Human Peripheral Blood Mononuclear Cells Exposed to Lassa Virus and to the Attenuated Mopeia/Lassa Reassortant 29 (ML29), a Vaccine Candidate
  • Document date: 2013_9_12
  • ID: 0epeljaf_48
    Snippet: Bleeding is not a salient manifestation in most cases of LF. In contrast to South American arenaviral HF caused by Junín and Machupo viruses, disseminated intravascular coagulation (DIC) is rarely seen in LF patients. Nevertheless, virus-induced coagulation abnormalities and impaired vascular function is a hallmark of LF pathogenesis [3] , [86] . Platelets remain either normal or moderately low, but with significantly reduced function. Plasma fr.....
    Document: Bleeding is not a salient manifestation in most cases of LF. In contrast to South American arenaviral HF caused by Junín and Machupo viruses, disseminated intravascular coagulation (DIC) is rarely seen in LF patients. Nevertheless, virus-induced coagulation abnormalities and impaired vascular function is a hallmark of LF pathogenesis [3] , [86] . Platelets remain either normal or moderately low, but with significantly reduced function. Plasma from LF patients has inhibitory activity on platelets from healthy individuals, suggesting the presence of soluble factors causing platelets malfunction [88] . Our previous work supports the notion that LASV can replicate vigorously in endothelial cells without cytopathic effects but with reduced cell function, such as reduced production of interleukin IL-8 [18] .

    Search related documents:
    Co phrase search for related documents
    • cell function and endothelial cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47
    • cell function and impaired vascular function: 1
    • cell function and inhibitory activity: 1, 2, 3
    • cell function and previous work: 1, 2, 3, 4
    • cell function and reduce cell function: 1, 2, 3, 4, 5
    • cell function and reduce production: 1, 2
    • cell function and soluble factor: 1, 2
    • cell function and vascular function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • cell function and virus induce: 1
    • coagulation abnormality and DIC intravascular coagulation: 1
    • coagulation abnormality and intravascular coagulation: 1
    • cytopathic effect and DIC intravascular coagulation: 1
    • cytopathic effect and endothelial cell: 1
    • cytopathic effect and inhibitory activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • cytopathic effect and intravascular coagulation: 1
    • cytopathic effect and previous work: 1, 2
    • cytopathic effect and reduce production: 1, 2
    • cytopathic effect and significantly reduce: 1, 2
    • cytopathic effect and virus induce: 1, 2, 3